Investir Dans Les Biotechs

Investir Dans Les Biotechs

File Name: d417d2814

Size: 41231 KB

Last Upload: 03, March 2019

Download Now Read Free

fund in the news source date title press release 27 februari 2019 minoryx therapeutics receives approval from spanish regulatory agency to initiate phase 2 study in friedreichs ataxia press release 26 februari 2019 immunic therapeutics announces first patient enrolled in phase 2 clinical trial of imu 838 an oral therapy for patients with relapsing remitting multiple sclerosis lecho 16